Supplementary Figure 2 from The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Year: 2023
Type: supplementary-materials
Abstract: The STAT3 inhibitor galiellalactone inhibits the transcriptional activity of STAT3 without reducing its phosphorylation
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362494532
